サマリー

ホスホイノシチド3キナーゼ（PI3K）阻害剤の世界市場 2024-2028
ホスホイノシチド3-キナーゼ（PI3K）阻害剤市場は、2023年から2028年にかけて8818万米ドルの成長が予測され、予測期間中のCAGRは5.54%で加速すると予測されています。当レポートでは、ホスホイノシチド3-キナーゼ（PI3K）阻害剤市場について、市場規模や予測、動向、成長促進要因、課題などの全体的な分析に加え、約25のベンダーを網羅したベンダー分析も掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、血液療法の最近の承認、ベンダーの戦略的提携、特別な効能を持つ医薬品の指定によって牽引されています。
Technavio社のホスホイノシチド3キナーゼ（PI3K）阻害剤市場は以下のように区分される：
用途別
- CLL（慢性リンパ性白血病
- FL
- その他の適応症
流通チャネル別
- 病院薬局
- 小売薬局
- オンライン薬局
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、今後数年間におけるホスホイノシチド3-キナーゼ（PI3K）阻害剤市場の成長を促進する主な理由の1つとして、研究適応症の拡大を挙げている。また、保険償還プログラムの採用が増加し、癌に対する意識が高まっていることも、市場の大きな需要につながると考えられます。
本レポートでは、ホスホイノシチド3-キナーゼ（PI3K）阻害剤市場について、以下の分野をカバーしています：
- ホスホイノシチド3キナーゼ（PI3K）阻害剤市場のサイジング
- ホスホイノシチド3キナーゼ（PI3K）阻害剤市場予測
- ホスホイノシチド3-キナーゼ（PI3K）阻害剤市場の産業分析
本レポートでは、ホスホイノシチド3-キナーゼ（PI3K）阻害剤市場の主要ベンダーの詳細な分析を提供しています、Bayer AG、Celon Pharma SA、Curis Inc.、Eli Lilly and Co.、Exelixis Inc.、F. Hoffmann La Roche Ltd.、Gilead Sciences Inc.、Merck KGaA、Molecular Depot LLC、Novartis AG、TG Therapeutics Inc.、Verastem Inc.、Secura Bio Inc.などです。また、ホスホイノシチド3-キナーゼ（PI3K）阻害剤市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を練り、来るべき成長機会をすべて活用するのに役立つものである。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、以下をご覧ください - [https://www.technavio.com/report/phosphoinositide-3-kinase-PI3K-inhibitors-market-industry-analysis](https://www.technavio.com/report/phosphoinositide-3-kinase-pi3k-inhibitors-market-industry-analysis)
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global phosphoinositide 3-kinase (PI3K) inhibitors market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global phosphoinositide 3-kinase (pi3k) inhibitors market 2018 - 2022 ($ million)
o 4.2 Application Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ million)
o 4.3 Distribution Channel Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Application
o 6.1 Market segments
o Exhibit 30: Chart on Application - Market share 2023-2028 (%)
o Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
o 6.2 Comparison by Application
o Exhibit 32: Chart on Comparison by Application
o Exhibit 33: Data Table on Comparison by Application
o 6.3 CLL - Market size and forecast 2023-2028
o Exhibit 34: Chart on CLL - Market size and forecast 2023-2028 ($ million)
o Exhibit 35: Data Table on CLL - Market size and forecast 2023-2028 ($ million)
o Exhibit 36: Chart on CLL - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on CLL - Year-over-year growth 2023-2028 (%)
o 6.4 FL - Market size and forecast 2023-2028
o Exhibit 38: Chart on FL - Market size and forecast 2023-2028 ($ million)
o Exhibit 39: Data Table on FL - Market size and forecast 2023-2028 ($ million)
o Exhibit 40: Chart on FL - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on FL - Year-over-year growth 2023-2028 (%)
o 6.5 Other indications - Market size and forecast 2023-2028
o Exhibit 42: Chart on Other indications - Market size and forecast 2023-2028 ($ million)
o Exhibit 43: Data Table on Other indications - Market size and forecast 2023-2028 ($ million)
o Exhibit 44: Chart on Other indications - Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Other indications - Year-over-year growth 2023-2028 (%)
o 6.6 Market opportunity by Application
o Exhibit 46: Market opportunity by Application ($ million)
o Exhibit 47: Data Table on Market opportunity by Application ($ million)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 48: Chart on Distribution Channel - Market share 2023-2028 (%)
o Exhibit 49: Data Table on Distribution Channel - Market share 2023-2028 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 50: Chart on Comparison by Distribution Channel
o Exhibit 51: Data Table on Comparison by Distribution Channel
o 7.3 Hospital pharmacies - Market size and forecast 2023-2028
o Exhibit 52: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
o Exhibit 53: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
o Exhibit 54: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
o 7.4 Retail pharmacies - Market size and forecast 2023-2028
o Exhibit 56: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
o Exhibit 57: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
o Exhibit 58: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
o 7.5 Online pharmacies - Market size and forecast 2023-2028
o Exhibit 60: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
o Exhibit 61: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
o Exhibit 62: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
o Exhibit 63: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
o 7.6 Market opportunity by Distribution Channel
o Exhibit 64: Market opportunity by Distribution Channel ($ million)
o Exhibit 65: Data Table on Market opportunity by Distribution Channel ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 69: Chart on Geographic comparison
o Exhibit 70: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 Germany - Market size and forecast 2023-2028
o Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
o Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
o Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
o 9.9 China - Market size and forecast 2023-2028
o Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million)
o Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
o Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
o 9.10 Canada - Market size and forecast 2023-2028
o Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ million)
o Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
o Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
o 9.11 UK - Market size and forecast 2023-2028
o Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ million)
o Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ million)
o Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%)
o Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 107: Market opportunity By Geographical Landscape ($ million)
o Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 113: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 115: AbbVie Inc. - Overview
o Exhibit 116: AbbVie Inc. - Product / Service
o Exhibit 117: AbbVie Inc. - Key news
o Exhibit 118: AbbVie Inc. - Key offerings
o 12.4 Bayer AG
o Exhibit 119: Bayer AG - Overview
o Exhibit 120: Bayer AG - Business segments
o Exhibit 121: Bayer AG - Key news
o Exhibit 122: Bayer AG - Key offerings
o Exhibit 123: Bayer AG - Segment focus
o 12.5 Celon Pharma SA
o Exhibit 124: Celon Pharma SA - Overview
o Exhibit 125: Celon Pharma SA - Business segments
o Exhibit 126: Celon Pharma SA - Key offerings
o Exhibit 127: Celon Pharma SA - Segment focus
o 12.6 Curis Inc.
o Exhibit 128: Curis Inc. - Overview
o Exhibit 129: Curis Inc. - Product / Service
o Exhibit 130: Curis Inc. - Key offerings
o 12.7 Eli Lilly and Co.
o Exhibit 131: Eli Lilly and Co. - Overview
o Exhibit 132: Eli Lilly and Co. - Product / Service
o Exhibit 133: Eli Lilly and Co. - Key news
o Exhibit 134: Eli Lilly and Co. - Key offerings
o 12.8 Exelixis Inc.
o Exhibit 135: Exelixis Inc. - Overview
o Exhibit 136: Exelixis Inc. - Product / Service
o Exhibit 137: Exelixis Inc. - Key offerings
o 12.9 F. Hoffmann La Roche Ltd.
o Exhibit 138: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 139: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 140: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 141: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 142: F. Hoffmann La Roche Ltd. - Segment focus
o 12.10 Gilead Sciences Inc.
o Exhibit 143: Gilead Sciences Inc. - Overview
o Exhibit 144: Gilead Sciences Inc. - Product / Service
o Exhibit 145: Gilead Sciences Inc. - Key news
o Exhibit 146: Gilead Sciences Inc. - Key offerings
o 12.11 Merck KGaA
o Exhibit 147: Merck KGaA - Overview
o Exhibit 148: Merck KGaA - Business segments
o Exhibit 149: Merck KGaA - Key news
o Exhibit 150: Merck KGaA - Key offerings
o Exhibit 151: Merck KGaA - Segment focus
o 12.12 Molecular Depot LLC
o Exhibit 152: Molecular Depot LLC - Overview
o Exhibit 153: Molecular Depot LLC - Product / Service
o Exhibit 154: Molecular Depot LLC - Key offerings
o 12.13 Novartis AG
o Exhibit 155: Novartis AG - Overview
o Exhibit 156: Novartis AG - Business segments
o Exhibit 157: Novartis AG - Key offerings
o Exhibit 158: Novartis AG - Segment focus
o 12.14 Secura Bio Inc.
o Exhibit 159: Secura Bio Inc. - Overview
o Exhibit 160: Secura Bio Inc. - Product / Service
o Exhibit 161: Secura Bio Inc. - Key offerings
o 12.15 TG Therapeutics Inc.
o Exhibit 162: TG Therapeutics Inc. - Overview
o Exhibit 163: TG Therapeutics Inc. - Product / Service
o Exhibit 164: TG Therapeutics Inc. - Key offerings
o 12.16 Verastem Inc.
o Exhibit 165: Verastem Inc. - Overview
o Exhibit 166: Verastem Inc. - Product / Service
o Exhibit 167: Verastem Inc. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 168: Inclusions checklist
o Exhibit 169: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 170: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 171: Research methodology
o Exhibit 172: Validation techniques employed for market sizing
o Exhibit 173: Information sources
o 13.5 List of abbreviations
o Exhibit 174: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global phosphoinositide 3-kinase (pi3k) inhibitors market 2018 - 2022 ($ million)
Exhibits19: Historic Market Size - Application Segment 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Application - Market share 2023-2028 (%)
Exhibits31: Data Table on Application - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on CLL - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on CLL - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on CLL - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on CLL - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on FL - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on FL - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on FL - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on FL - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Other indications - Market size and forecast 2023-2028 ($ million)
Exhibits43: Data Table on Other indications - Market size and forecast 2023-2028 ($ million)
Exhibits44: Chart on Other indications - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Other indications - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Application ($ million)
Exhibits47: Data Table on Market opportunity by Application ($ million)
Exhibits48: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits49: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by Distribution Channel
Exhibits51: Data Table on Comparison by Distribution Channel
Exhibits52: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits53: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits54: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits57: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits58: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits61: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits62: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits64: Market opportunity by Distribution Channel ($ million)
Exhibits65: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits100: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits101: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits104: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits105: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ million)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits109: Impact of drivers and challenges in 2023 and 2028
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: AbbVie Inc. - Overview
Exhibits116: AbbVie Inc. - Product / Service
Exhibits117: AbbVie Inc. - Key news
Exhibits118: AbbVie Inc. - Key offerings
Exhibits119: Bayer AG - Overview
Exhibits120: Bayer AG - Business segments
Exhibits121: Bayer AG - Key news
Exhibits122: Bayer AG - Key offerings
Exhibits123: Bayer AG - Segment focus
Exhibits124: Celon Pharma SA - Overview
Exhibits125: Celon Pharma SA - Business segments
Exhibits126: Celon Pharma SA - Key offerings
Exhibits127: Celon Pharma SA - Segment focus
Exhibits128: Curis Inc. - Overview
Exhibits129: Curis Inc. - Product / Service
Exhibits130: Curis Inc. - Key offerings
Exhibits131: Eli Lilly and Co. - Overview
Exhibits132: Eli Lilly and Co. - Product / Service
Exhibits133: Eli Lilly and Co. - Key news
Exhibits134: Eli Lilly and Co. - Key offerings
Exhibits135: Exelixis Inc. - Overview
Exhibits136: Exelixis Inc. - Product / Service
Exhibits137: Exelixis Inc. - Key offerings
Exhibits138: F. Hoffmann La Roche Ltd. - Overview
Exhibits139: F. Hoffmann La Roche Ltd. - Business segments
Exhibits140: F. Hoffmann La Roche Ltd. - Key news
Exhibits141: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits142: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits143: Gilead Sciences Inc. - Overview
Exhibits144: Gilead Sciences Inc. - Product / Service
Exhibits145: Gilead Sciences Inc. - Key news
Exhibits146: Gilead Sciences Inc. - Key offerings
Exhibits147: Merck KGaA - Overview
Exhibits148: Merck KGaA - Business segments
Exhibits149: Merck KGaA - Key news
Exhibits150: Merck KGaA - Key offerings
Exhibits151: Merck KGaA - Segment focus
Exhibits152: Molecular Depot LLC - Overview
Exhibits153: Molecular Depot LLC - Product / Service
Exhibits154: Molecular Depot LLC - Key offerings
Exhibits155: Novartis AG - Overview
Exhibits156: Novartis AG - Business segments
Exhibits157: Novartis AG - Key offerings
Exhibits158: Novartis AG - Segment focus
Exhibits159: Secura Bio Inc. - Overview
Exhibits160: Secura Bio Inc. - Product / Service
Exhibits161: Secura Bio Inc. - Key offerings
Exhibits162: TG Therapeutics Inc. - Overview
Exhibits163: TG Therapeutics Inc. - Product / Service
Exhibits164: TG Therapeutics Inc. - Key offerings
Exhibits165: Verastem Inc. - Overview
Exhibits166: Verastem Inc. - Product / Service
Exhibits167: Verastem Inc. - Key offerings
Exhibits168: Inclusions checklist
Exhibits169: Exclusions checklist
Exhibits170: Currency conversion rates for US$
Exhibits171: Research methodology
Exhibits172: Validation techniques employed for market sizing
Exhibits173: Information sources
Exhibits174: List of abbreviations